Advertisement

Research Article Free access | 10.1172/JCI117039

Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.

J F Keaney Jr, J M Gaziano, A Xu, B Frei, J Curran-Celentano, G T Shwaery, J Loscalzo, and J A Vita

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Find articles by Keaney, J. in: JCI | PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Find articles by Gaziano, J. in: JCI | PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Find articles by Xu, A. in: JCI | PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Find articles by Frei, B. in: JCI | PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Find articles by Curran-Celentano, J. in: JCI | PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Find articles by Shwaery, G. in: JCI | PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Find articles by Loscalzo, J. in: JCI | PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Find articles by Vita, J. in: JCI | PubMed | Google Scholar

First published February 1, 1994 - More info

Published in Volume 93, Issue 2 (February 1, 1994)
J Clin Invest. 1994;93(2):844–851. doi:10.1172/JCI117039.
Copyright © 1994, The American Society for Clinical Investigation.

Published February 1, 1994 ; Accepted: date unavailable
Abstract

Abnormalities in endothelium-dependent arterial relaxation develop early in atherosclerosis and may, in part, result from the effects of modified low-density lipoprotein (LDL) on agonist-mediated endothelium-derived relaxing factor (EDRF) release and EDRF degradation. alpha-Tocopherol (AT) is the main lipid-soluble antioxidant in human plasma and lipoproteins, therefore, we investigated the effects of AT on endothelium-dependent arterial relaxation in male New Zealand White rabbits fed diets containing (a) no additive (controls), (b) 1% cholesterol (cholesterol group), or 1% cholesterol with either (c) 1,000 IU/kg chow AT (low-dose AT group) or (d) 10,000 IU/kg chow AT (high-dose AT group). After 28 d, we assayed endothelial function and LDL susceptibility to ex vivo copper-mediated oxidation. Acetylcholine-and A23187-mediated endothelium-dependent relaxations were significantly impaired in the cholesterol group (P < 0.001 vs. control), but preserved in the low-dose AT group (P = NS vs. control). Compared to the control and cholesterol groups, vessels from the high-dose AT group demonstrated profound impairment of arterial relaxation (P < 0.05) and significantly more intimal proliferation than other groups (P < 0.05). In normal vessels, alpha-tocopherol had no effect on endothelial function. LDL derived from both the high- and low-dose AT groups was more resistant to oxidation than LDL from control animals (P < 0.05). These data indicate that modest dietary treatment with AT preserves endothelial vasodilator function in cholesterol-fed rabbits while a higher dose of AT is associated with endothelial dysfunction and enhanced intimal proliferation despite continued LDL resistance to ex vivo copper-mediated oxidation.

Images
Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (February 1, 1994): No description
Advertisement
Advertisement